These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6187642)

  • 1. Differences between normal antithrombin III and antithrombin III Padua as determined by laser nephelometry.
    Girolami A; Saggin L; Sticchi A; Ruffato G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(6):895-900. PubMed ID: 6187642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of laser nephelometer in the study of abnormal clotting factors: characterization of two abnormal antithrombins (AT III Padua and AT III Padua2).
    Girolami A; Ruzza G; Saggin L; Sticchi A; Melizzi R
    Am J Clin Pathol; 1984 Mar; 81(3):323-8. PubMed ID: 6702724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombin III determination by rate (kinetic) nephelometry.
    Balla G; Misz M; Karmazsin L; Rák K
    Thromb Haemost; 1984 Feb; 51(1):9-11. PubMed ID: 6426081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in antithrombin III values during and after extracorporeal circulation in heart surgery, measured on the day of operation using a chromogenic substrate and a laser nephelometer].
    Hopmeier P; Heuss F; Fischer M
    Wien Klin Wochenschr; 1984 Dec; 96(24):881-4. PubMed ID: 6528618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombin evaluation as obtained by kinetics studies of antigen-antibody reaction in a laser nephelometer.
    Girolami A; Sticchi A; Melizzi R; Saggin L; Ruzza G
    Thromb Haemost; 1984 Aug; 52(1):15-8. PubMed ID: 6495258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin III Padua: a "new" congenital antithrombin III abnormality with normal or near normal activity, normal antigen, abnormal migration and no thrombotic disease.
    Girolami A; Pengo V; Cappellato G; Vianello C; Procidano M; Cartei C
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(1):98-111. PubMed ID: 6192061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laser nephelometer evaluation of factor IX.
    Ruzza G; Lazzaro AR; Viero ML; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):843-9. PubMed ID: 1713891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laser nephelometric quantitation of antithrombin-III (AT-III) development of a new assay.
    Parvez Z; Fareed J; Messmore HL; Moncada R
    Thromb Res; 1981 Dec 1-15; 24(5-6):367-77. PubMed ID: 6806931
    [No Abstract]   [Full Text] [Related]  

  • 9. Monitoring plasma antithrombin-III levels during infusion of antithrombin-III concentrate.
    Jespersen J
    Thromb Haemost; 1984 Oct; 52(2):214. PubMed ID: 6523438
    [No Abstract]   [Full Text] [Related]  

  • 10. Antithrombin III levels in term and preterm infants measured by rate nephelometry.
    Karmazsin L; Balla G; Misz M; Beck P; Nagy P; Rák K
    Acta Paediatr Hung; 1984; 25(1-2):119-26. PubMed ID: 6477763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The determination of antithrombin III, alpha 2-macroglobulin and alpha 2-antiplasmin in plasma by laser nephelometry.
    Schmitz-Huebner U; Nachbar J; Asbeck F
    J Clin Chem Clin Biochem; 1980 Apr; 18(4):221-5. PubMed ID: 6155426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breed, age, and gender differences in plasma antithrombin-III activity in clinically normal young horses.
    Johnstone IB; Physick-Sheard P; Crane S
    Am J Vet Res; 1989 Oct; 50(10):1751-3. PubMed ID: 2802307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of antithrombin III by kinetic nephelometry (comparative studies in chronic liver diseases)].
    Misz M; Balla G; Karmazsin L; Beck P; Rák K
    Orv Hetil; 1983 Nov; 124(45):2731-5. PubMed ID: 6657230
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
    Bohner J; von Pape KW; Blaurock M
    Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoturbidimetric measurement of cold insoluble globulin with reference to a laser nephelometric assay.
    Gressner AM; Wallraff P
    J Clin Chem Clin Biochem; 1981 Dec; 19(12):1213-5. PubMed ID: 7328389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immuno turbidimetric assay of heparin cofactor II].
    Takahashi K; Yamagishi R; Sakuragawa N; Shimamoto M; Ohsawa T; Kita M
    Rinsho Byori; 1988 Aug; 36(8):947-51. PubMed ID: 3241422
    [No Abstract]   [Full Text] [Related]  

  • 18. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin III (AT III) Padua2: a "new" congenital abnormality with defective heparin co-factor activities but no thrombotic disease.
    Girolami A; Fabris F; Cappellato G; Sainati L; Boeri G
    Blut; 1983 Aug; 47(2):93-103. PubMed ID: 6871478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.